TherapeuticsMD, Inc. Research And Development Expense

Quick Answer

TherapeuticsMD, Inc. reported Research And Development Expense of $7.09 million for the year ending 2021.

  • TherapeuticsMD, Inc. showed a decrease of -32.1% in Research And Development Expense from 2020 to 2021.
  • This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2022.
  • XBRL data for this metric is available from 2011 to 2021 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2011: $54.7 thousand | Q2 2011: $106.0 thousand | Q3 2011: $95.2 thousand | Q1 2012: $412.0 thousand | Q2 2012: $833.3 thousand | Q3 2012: $1.70 million | Q1 2013: $1.57 million | Q2 2013: $1.75 million | Q3 2013: $4.10 million | Q1 2014: $5.91 million | Q2 2014: $8.23 million | Q3 2014: $14.91 million | Q1 2015: $18.18 million | Q2 2015: $24.19 million | Q3 2015: $16.42 million | Q1 2016: $15.10 million | Q2 2016: $13.84 million | Q3 2016: $14.66 million | Q1 2017: $7.72 million | Q2 2017: $8.72 million | Q3 2017: $6.44 million | Q1 2018: $7.04 million | Q2 2018: $6.80 million | Q3 2018: $6.71 million | Q1 2019: $6.32 million | Q2 2019: $4.96 million | Q3 2019: $4.08 million | Q1 2020: $3.27 million | Q2 2020: $2.74 million | Q3 2020: $2.03 million | Q1 2021: $2.05 million | Q2 2021: $2.01 million | Q3 2021: $1.61 million | Q1 2022: $1.40 million | Q2 2022: $1.58 million | Q3 2022: $1.11 million.
  • Over the full 11 years of available data (2011 to 2021), TherapeuticsMD, Inc.'s Research And Development Expense has grown by 6,507.5%.
  • Historical annual values: Fiscal year 2021: $7.09 million | Fiscal year 2020: $10.43 million | Fiscal year 2019: $19.79 million | Fiscal year 2018: $27.30 million | Fiscal year 2017: $33.85 million | Fiscal year 2016: $53.94 million | Fiscal year 2015: $72.04 million | Fiscal year 2014: $43.22 million | Fiscal year 2013: $13.55 million | Fiscal year 2012: $4.49 million | Fiscal year 2011: $107.2 thousand.
  • Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: